Relationship between metabolism and biomass of medically important zygomycetes

被引:9
作者
Antachopoulos, Charalampos
Meletiadis, Joseph
Roilides, Emmanuel
Sein, Tin
Sutton, Deanna A.
Wickes, Brian L.
Rinaldi, Michael G.
Merz, William G.
Shea, Yvonne R.
Walsh, Thomas J.
机构
[1] NCI, Pediat Oncol Branch, CRC, Immuncompromised Host Sect, Bethesda, MD 20892 USA
[2] Aristotle Univ Thessaloniki, Dept Pediat, Hippokration Hosp, GR-54006 Thessaloniki, Greece
[3] Univ Texas, Hlth Sci Ctr San Antonio, Fungus Testing Lab, San Antonio, TX 78285 USA
[4] Univ Texas, Hlth Sci Ctr San Antonio, Dept Microbiol, Adv DNA Technol Core Facil, San Antonio, TX 78285 USA
[5] Johns Hopkins Univ Hosp, Dept Pathol, Microbiol Lab, Baltimore, MD 21287 USA
[6] NIH, Microbiol Serv, Dept Lab Med, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA
关键词
zygomycetes; XTT; fungal growth; metabolic activity; Boltzmann model;
D O I
10.1080/13693780600644878
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Little is known about the relationships between metabolic activity and fungal biomass or time of incubation for medically important fungal pathogens. Understanding these relationships may be especially relevant for rapidly growing organisms, such as zygomycetes. A range of inocula of five clinical isolates of zygomycetes (one each of Rhizopus oryzae, Rhizopus microsporus, Cunninghamella bertholletiae, Mucor circinelloides and Absidia corymbifera) were incubated for 6, 8, 12, 24 and 48 h, after which hyphal mass was assessed spectrophotometrically and metabolic activity was measured using various concentrations of XTT and menadione. Both linear regression and the Boltzmann sigmoid model were used and compared for description of relationships between metabolic activity, biomass and time of incubation. Modeling was further applied to eleven additional zygomycete isolates. The relationships of biomass or metabolic activity as a function of time of incubation were well described with the Boltzmann sigmoid model. The latter was superior to linear regression in describing the relationship between metabolic activity and fungal biomass. For all isolates of zygomycetes, increases in metabolic activity preceded increases in biomass. Inter-species differences in growth patterns were observed, with Rhizopus microsporus and Mucor spp. reaching the plateau of growth earlier compared to other species. These findings on the temporal relationship and inter-species differences of hyphal growth and metabolic activity for zygomycetes may be useful in the design and interpretation of in vitro studies of these emerging pathogens.
引用
收藏
页码:429 / 438
页数:10
相关论文
共 26 条
[1]  
[Anonymous], 1990, PCR PROTOCOLS, DOI DOI 10.1016/B978-0-12-372180-8.50042-1
[2]   Physiological responses of chemostat cultures of Aspergillus niger (B1-D) to simulated and actual oxidative stress [J].
Bai, ZH ;
Harvey, LM ;
McNeil, B .
BIOTECHNOLOGY AND BIOENGINEERING, 2003, 82 (06) :691-701
[3]   Metabolic activity in filamentous fungi can be analysed by flow cytometry [J].
Bradner, JR ;
Nevalainen, KMH .
JOURNAL OF MICROBIOLOGICAL METHODS, 2003, 54 (02) :193-201
[4]  
Burnham K. P., 2002, MODEL SELECTION MULT
[5]   Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi [J].
EspinelIngroff, A ;
Bartlett, M ;
Bowden, R ;
Chin, NX ;
Cooper, C ;
Fothergill, A ;
McGinnis, MR ;
Menezes, P ;
Messer, SA ;
Nelson, PW ;
Odds, FC ;
Pasarell, L ;
Peter, J ;
Pfaller, MA ;
Rex, JH ;
Rinaldi, MG ;
Shankland, GS ;
Walsh, TJ ;
Weitzman, I .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) :139-143
[6]   Interferon-γ and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important Zygomycetes [J].
Gil-Lamaignere, C ;
Simitsopoulou, M ;
Roilides, E ;
Maloukou, A ;
Winn, RM ;
Walsh, TJ .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (07) :1180-1187
[7]   Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the Standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents [J].
Hawser, SP ;
Norris, H ;
Jessup, CJ ;
Ghannoum, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (05) :1450-1452
[8]   Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class of compounds [J].
Hawser, SP ;
Jessup, C ;
Vitullo, J ;
Ghannoum, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (07) :2738-2741
[9]   Zygomycosis in a Tertiary-Care Cancer Center in the era of Aspergillus-active antifungal therapy:: A case-control observational study of 27 recent cases [J].
Kontoyiannis, DP ;
Lionakis, MS ;
Lewis, RE ;
Chamilos, G ;
Healy, M ;
Perego, C ;
Safdar, A ;
Kantarjian, H ;
Champlin, R ;
Walsh, TJ ;
Raad, II .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (08) :1350-1360
[10]   Uses and limitations of the XTT assay in studies of Candida growth and metabolism [J].
Kuhn, DM ;
Balkis, M ;
Chandra, J ;
Mukherjee, PK ;
Ghannoum, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :506-508